West Pharmaceutical Services, Inc. (WST) vs Zimmer Biomet Holdings, Inc. (ZBH)
A side-by-side comparison of West Pharmaceutical Services, Inc. and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 13, 2026. Differences are shown without an overall score or investment verdict.
WST
West Pharmaceutical Services, Inc.
$347.15HealthcareDelayed quote: Aug 13, 2026, 3:00 PM EDT
ZBH
Zimmer Biomet Holdings, Inc.
$98.74HealthcareDelayed quote: Aug 13, 2026, 3:00 PM EDT
Total return — WST vs ZBH
growth of $100 · dividends reinvested · last 10yWST +349.3% (+16.2%/yr)ZBH -15.7% (-1.7%/yr)WST compounded faster over this window
Log scale — wide-divergence pair
WST ZBH
WST vs ZBH: by the numbers
- •WST is the larger company ($24.43B vs $19.10B market cap).
- •ZBH trades at the lower trailing earnings multiple (23.82 vs 45.05 P/E), one valuation lens rather than an overall verdict.
- •WST converts more revenue to profit (16.98% vs 9.48% net margin).
- •WST grew revenue faster over the past five years (5.68% vs 2.89% CAGR).
- •ZBH pays the higher dividend yield (0.98% vs 0.25%).
Metrics side by side
Valuation
| Metric | WST | ZBH |
|---|---|---|
| P/E ratio | 45.05 | 23.82 |
| Forward P/E | 39.39 | 11.48 |
| P/S ratio | 7.55 | 2.22 |
| P/B ratio | 8.40 | 1.50 |
| EV / EBITDA | 28.84 | 11.09 |
| FCF yield | 1.74% | 10.71% |
Profitability
| Metric | WST | ZBH |
|---|---|---|
| Gross margin | 36.77% | 61.62% |
| Operating margin | 20.64% | 15.73% |
| Net margin | 16.98% | 9.48% |
| ROE | 18.89% | 6.39% |
| ROIC | 13.62% | 5.48% |
Dividends
| Metric | WST | ZBH |
|---|---|---|
| Dividend yield | 0.25% | 0.98% |
| Payout ratio | 12.88% | 26.97% |
Growth (annualized)
| Metric | WST | ZBH |
|---|---|---|
| Revenue CAGR (5Y) | 5.68% | 2.89% |
| EPS CAGR (5Y) | 7.85% | N/A |
| FCF CAGR (5Y) | 8.74% | 8.63% |
| Total return CAGR (5Y) | -3.64% | -6.37% |
Frequently asked
- Which has the lower trailing P/E, WST or ZBH?
- ZBH has the lower trailing P/E: WST trades at 45.05 and ZBH at 23.82. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, WST or ZBH?
- Over the past five years, WST grew revenue faster — WST at a 5.68% CAGR versus ZBH at 2.89%.
- Does WST or ZBH pay a bigger dividend?
- WST yields 0.25% and ZBH yields 0.98% based on trailing dividends and the latest price.
- Is WST or ZBH more profitable?
- WST runs the higher net margin — WST at 16.98% versus ZBH at 9.48%.
- How have WST and ZBH total returns compared?
- Over the past 10 years, WST delivered 16.26% and ZBH delivered -1.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
West Pharmaceutical Services P/E ratioZimmer Biomet P/E ratioWest Pharmaceutical Services dividend yieldZimmer Biomet dividend yieldWest Pharmaceutical Services ROEZimmer Biomet ROEWest Pharmaceutical Services operating marginZimmer Biomet operating marginWest Pharmaceutical Services revenue growthZimmer Biomet revenue growthWest Pharmaceutical Services free cash flowZimmer Biomet free cash flow
West Pharmaceutical Services & Zimmer Biomet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 13, 2026.